We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

2 FTSE 100 income champions I’d buy to retire on

One of these FTSE 100 (INDEXFTSE: UKX) companies has seen its shares soar by 30% in 2019, so read on to find out more.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Reckitt Benckiser Group (LSE: RB) shares have dropped back over the past two years, though they had previously reached P/E valuations in the twenties. There have been concerns over its pharmaceuticals business, though some of the high valuation would surely have been as a result of a ‘flight to safety’ triggered by a few tumultuous stock market years, so it’s arguable that it was a deserved correction.

Solid record

Nevertheless, the shares are actually still up 27% over the past five years, while the FTSE 100 has managed a meagre 8% — and Reckitt Benckiser has been reporting steady earnings gains and lifting its dividend every year.

Should you buy Reckitt Benckiser Group Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

We’re looking at forecast dividend yields of around the 3% mark, so not among the biggest, but with such a great track record of progressive rises I rate Reckitt Benckiser as a long-term dividend champion.

According to chief executive Rakesh Kapoor, “Q1 saw a slow start to the year, especially in OTC.” But he went on to say that “we expect to see improving growth in the remainder of the year, particularly in H2.”

E-commerce

A key point for me is that e-commerce is making inroads, up 25% in the first quarter and now accounting for 10% of revenue in the firm’s health business.

The City is expecting a modest EPS improvement of 2% this year, and though it’s still early, Reckitt Benckiser says it’s on course to meet full-year targets. The firm’s outlook for like-for-like revenue growth is put at 3%-4%, with adjusted operating margins expected to remain stable.

For a retirement portfolio, I see shares like Reckitt Benckiser’s as ideal for forming a bedrock of very safe companies with dependable long-term dividend income streams.

Wealth

Investment manager Schroders (LSE: SDR) is another I see as a good long-term income provider, and it is also off to a decent start in 2019.

At the end of the first quarter, total assets under management were up 4.2% to £424.4bn, comprising a 4% rise to £377.9bn in the firm’s Asset Management business itself, and a 6.4% jump in Wealth Management to £46.5bn.

The dividend should be flat this year, with a small boost predicted for 2020, providing well-covered yields of 4.2% and 4.3% respectively. Though that doesn’t represent any rise this year, the dividend has still soared from 78p per share in 2014 to 114p last year, and 46% in just four years is not to be sniffed at.

The Schroders share price has been volatile over the past five years, and that can happen with fund managers — their shares can climb and fall disproportionately as stock market sentiment waxes and wanes. That resulted in a bit of a disaster in 2018, with a loss of 30%.

Low valuation

But it left the shares on a P/E multiple of only 11.3 at the end of the year, which looks very much like a bottom-of-the-cycle valuation to me.

In December, my colleague Rupert Hargreaves named Schroders as one of the FTSE 100 dividend stocks he’d buy before 2019. That’s turned out to be a bit of astute timing, as the Schroders share price has soared by 30% so far this year. And we’re still looking at what I consider undemanding P/E valuations of around 13.

While Schroders’ volatility might put off some investors who are already retired, I’m certainly seeing a stock I’d buy to build a retirement portfolio.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

ISA coins
Investing Articles

How much would a Stocks and Shares ISA need to replace a £3,064 monthly salary?

Andrew Mackie explores how a Stocks and Shares ISA can power long-term passive income through quality compounders and disciplined investing…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

Nvidia’s CEO thinks this company could hit $1trn! Should I add it to my list of stocks to buy?

When hunting for stocks to buy, Mark Hartley is usually wary of US tech hype. But an endorsement like this…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

Not sure what a SIPP is? 3 reasons it could pay to know!

Christopher Ruane digs into some of the details of a SIPP and highlights a trio of possible benefits he sees…

Read more »

Investing Articles

Lloyds shares have done nothing for almost half a year — are they stuck at £1?

Mark Hartley takes a closer look at why his Lloyds' shares have barely moved in 2026, but finds reassurance in…

Read more »

Businesswoman calculating finances in an office
Investing Articles

Forget waiting for the IPOs: here’s how to invest in SpaceX and Anthropic today

SpaceX and Anthropic IPOs in 2026 are going to be huge. But investors don’t need to wait for them to…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

2 FTSE investment trusts to consider for passive income in 2026

Ben McPoland spotlights a pair of struggling investment trusts, one of which has crashed 50%. Why does he think they…

Read more »

Tesla car at super charger station
Investing Articles

How much impact could a SpaceX merger have on the Tesla share price?

A SpaceX IPO could be the biggest in history and if Musk's merger plans go ahead, it could save the…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

£5,000 invested in Greggs shares 2 years ago is now worth…

Greggs' shares have been a diabolical investment over the last two years. But could they offer value today given they’ve…

Read more »